When a product is ready to leave testing
The questions we ask before a build stops being a build.
"Ready" is the least useful word in a release meeting. It means the tests pass, or the feature list is complete, or someone has run out of time — and those are very different states to be in on the morning of a rollout.
So the quality pod asks a fixed set of questions instead. Has every core flow been run against real operational data, not fixtures? Does the product behave when a dependency is slow rather than absent? Can we see, from production telemetry alone, that a user completed the thing they came to do? Is there a runbook for the three failures we consider most likely?
None of those are pass or fail on their own. Together they turn a judgement call into a conversation with evidence in it, which is what makes it possible for one person to say "not yet" without it becoming an argument about confidence.
The other half is deciding what leaving testing actually buys you. For InsuraVault it means a controlled pilot, not general availability — the gap between those two is where most of the risk lives, and naming it explicitly has saved us from at least one rollout we would have regretted.